Ciba to offer PURE antimicrobial
This article was originally published in The Rose Sheet
Executive Summary
San Diego, Calif.-based PURE Bioscience has inked a deal with Swiss ingredient supplier Ciba to market and sell PURE's new antimicrobial in the personal-care market, firms announce Dec. 1. Antimicrobial is silver dihydrogen citrate, a stabilized ionic silver compound that formulates readily with other ingredients, firm says. PURE says its patented formula differs from competitors' in that it offers "superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it"; also it is manufactured in an environmentally friendly manner that creates no waste or byproducts. Under the terms of the deal, Ciba holds exclusive marketing rights for personal care under trade name Ciba Tinosan SDC. "With this technology from PURE Bioscience, we are able to support customers in the personal and household care industries as they strive to enhance the antimicrobial effects and shelf life of their formulations," says Catherine Ehrenberger, global head of Ciba Home & Personal Care. "We are especially excited about the opportunities in the cosmetics market, where manufacturers are increasingly expected to deliver antimicrobial benefits without compromising the look and feel of their products." Ciba is one of a number of stakeholders petitioning FDA to finalize its over-the-counter monograph for sunscreens